Last reviewed · How we verify
Acute Bacterial Otitis Media
Approved treatments
- Test formulation (Treatment A) · Pfizer
Clinical guidelines
- FDA label — 1L
Ceftriaxone is indicated for the treatment of acute bacterial otitis media caused by susceptible organisms.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute Bacterial Otitis Media patent landscape — cliff calendar, originator estates, attackable patents
- Acute Bacterial Otitis Media treatment landscape brief
- Acute Bacterial Otitis Media treatment updates RSS
Frequently asked questions about Acute Bacterial Otitis Media
What drugs treat Acute Bacterial Otitis Media?
Tracked treatments include Test formulation (Treatment A).
What is the treatment for Acute Bacterial Otitis Media?
Standard treatment for Acute Bacterial Otitis Media includes Test formulation (Treatment A). See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Acute Bacterial Otitis Media?
FDA label publishes guidelines for Acute Bacterial Otitis Media. 1 guideline references tracked.
Related
- Treatment landscape: Acute Bacterial Otitis Media patent cliff · Acute Bacterial Otitis Media CI report
- Treatment: Test formulation (Treatment A) · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing